Project Grant HT94252510583
Award Date 9/15/25
Completion Date 9/14/28
Dollars Obligated $443K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- The Defense Health Agency awarded The Wistar Institute of Anatomy and Biology a $1,101,574 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on immunotherapeutic targeting of SLC39A9 in CDKN2A-low melanoma. This 3-year grant, effective from September 15, 2025 to September 14, 2028, supports advanced biomedical research aimed at developing innovative medical solutions for military personnel and the broader public. The Wistar Institute,...
- The Department of Defense's Defense Health Agency awarded a $1,194,425 Project Grant to The Wistar Institute of Anatomy and Biology to support a 3-year research project titled "DEVELOPING RATIONAL APPROACHES FOR ACRAL MELANOMA" under the Military Medical Research and Development program (CFDA 12.420). The grant will fund basic, translational, and clinical research aimed at developing new treatments and advancing scientific understanding of acral melanoma, a rare form of skin cancer. As...
- The Department of Defense's Defense Health Agency awarded a $1,821,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Wistar Institute of Anatomy and Biology, an independent biomedical research institute in Philadelphia. The grant, awarded on May 15, 2024, supports research into the "Immunomodulatory Role of Acetate Metabolism in Breast Cancer" over a 3-year performance period ending on May 14, 2027. As a recognized leader in cancer,...
- The U.S. Defense Health Agency awarded a $999,006 Project Grant to The Wistar Institute of Anatomy and Biology in Philadelphia, PA under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will fund research on Epstein-Barr virus-driven B-cell inflammation and central nervous system trafficking in multiple sclerosis. The Wistar Institute has previously served as a subcontractor on federal grants, providing...
- The University of Pittsburgh has been awarded a $726,989 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMMUNOTHERAPEUTIC TARGETING OF SLC39A9 IN CDKN2A-LOW MELANOMA." The three-year award, commencing on September 15, 2025, aims to advance biomedical research to transform healthcare for military service members, veterans, and the broader public. The research project will investigate medical...
- The federal Project Grant award of $974,355.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Sanford Burnham Prebys Medical Discovery Institute. The award supports a research project entitled "WHITE ADIPOSE TISSUE SURROUNDING LYMPH NODES MODULATES ANTIMELANOMA IMMUNITY" with a performance period from July 1, 2024 to June 30, 2027. The funding will enable the Sanford Burnham Prebys Medical Discovery...
- This Project Grant award, titled "OVERCOMING IMMUNOTHERAPY RESISTANCE IN ACRAL MELANOMA", is provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $1,183,560 award to the University of Pittsburgh will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, running from September 1, 2025 to August 31, 2028, will focus on...
- The Institute For Cancer Research has been awarded a $940,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct a mouse model study of epigenetic events in melanomagenesis. This 3-year grant, with a period of performance from July 1, 2024 to June 30, 2027, will enable the non-profit research organization to investigate the underlying epigenetic mechanisms driving the development of melanoma. As a prime grantee, The...
- This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
- This Project Grant award, worth $647,861.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The funding will support a 3-year research project evaluating the interplay between B-cells and T-cells within the tumor microenvironment of melanoma, and the impact on immune checkpoint blockade therapies. The University of Pittsburgh, a major recipient of federal biomedical research grants, will...